Articles tagged with Depression
Researchers developed an individualized TMS targeting algorithm using large-scale brain imaging data to enhance treatment outcomes in depression. This approach, called MDD big data-guided individualized TMS targeting algorithm, produced targets more closely associated with symptom improvement.
A 4-year-old intervention program has been shown to effectively treat depression in young children, with a majority of participants achieving remission. The treatment, called PCIT-ED, helps parents interact with their children differently in the emotional domain, leading to improved mental health outcomes.
A new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging found that individuals with remitted depression show increased habenula activity and reduced connectivity between the habenula and dopamine-producing regions, suggesting a heightened sensitivity to negative cues. This suggests that even after recove...
A new study from the University of South Australia found that structured exercise programs improve symptoms of depression and anxiety in children. The study, involving 38,000 young people across 375 clinical trials, suggests benefits can emerge quickly, even for short periods of time.
Researchers found that lung cancer patients with both high levels of depression and inflammation at diagnosis had increasing depressive symptoms over the next eight months. These patients showed no changes in depression when only having high levels of depression or only high levels of inflammation, or neither. The study suggests an add...
Research synthesizes evidence from dozens of studies on polygenic scores and their clinical implications, revealing consistent patterns that could contribute to personalized psychiatric care. Higher genetic risk for depression correlates with poorer treatment outcomes, including nonresponse to antidepressants and mood stabilizers.
Researchers have identified a specific brain circuit, including vasopressin-producing neurons in the paraventricular nucleus, as critical drivers of depressive-like symptoms. Silencing these cells improves mood measures, while activating them exacerbates depressive-like behaviors.
A new study from the University of Pittsburgh suggests that excessive screen time and poor sleep quality may contribute to teen depression. The research found that teens who spent more time on screens and got less sleep had weaker brain connections, which can affect emotion regulation, memory, and attention.
This study found that increased screen time in late childhood was associated with more depressive symptoms, likely due to shorter sleep duration. Poor white matter organization during early adolescence may also contribute to this link.
A novel study in Biological Psychiatry highlights the layered and complex interactions between clinical symptoms and neurobiological sources of variation in depression. The research found that multiple brain profiles may manifest as the same clinical symptoms, supporting the presence of both one-to-one and many-to-one heterogeneity.
A McGill-led study found that combining ketamine with psychotherapy and a supportive environment can lead to longer-lasting depression relief. Patients experienced significant improvements in depression scores, suicidal thoughts, and anxiety after at least eight weeks.
A 16-year study of over 10,000 individuals aged 50+ found that those with higher wellbeing were more likely to have better scores on memory tests. The association was independent of depressive symptoms and suggested that psychological factors affect brain health.
Research from Mass General Brigham found that individuals with shorter telomeres and less optimal lifestyle choices are at greater risk for stroke, dementia, and late-life depression. However, those with healthier lifestyles showed no increased risk, suggesting a potential mitigation effect.
A new study suggests that analyzing brain network activity and inflammation levels could help tailor more effective therapies for teens and young adults with depression. Researchers found two distinct brain network patterns, with one subgroup showing improved cognitive function after receiving intermittent theta burst stimulation treat...
Dr. Stephen Ross's groundbreaking studies using psilocybin therapy have demonstrated rapid, substantial, and sustained improvements in psychological symptoms for patients with advanced cancer, substance use disorders, and major depressive disorder. His research has the potential to challenge conventional psychiatric medication approaches.
A new algorithm integrates large-scale group-level statistical maps with individual brain data to identify optimal TMS targets and predict patient outcomes. This approach has the potential to revolutionize precision psychiatry by providing more effective personalized treatments for depression.
A new study by researchers at The Hebrew University of Jerusalem finds that people with higher levels of depressive symptoms are more susceptible to the emotional influence of negative surrounding images. This effect was not mitigated by positive imagery, highlighting an asymmetry in how depression affects emotional processing.
A new study by UCL researchers found that stroke survivors who attend talking therapy sessions are more likely to recover from their psychological symptoms. The study analyzed data from 1.9 million patients, including 7,597 stroke survivors, and showed that 71% experienced reliable improvement in depression and anxiety.
A large study has found that cholesterol-lowering drugs do not have an antidepressive effect, contradicting previous small studies. The research, published in JAMA Psychiatry, involved 161 patients with depression and obesity, who received either statins or a placebo for 12 weeks.
A comprehensive review reveals that early ECT sessions show substantial improvement, but subsequent sessions may lead to diminishing returns and cognitive side effects. The researchers propose a response-guided sequential treatment strategy, categorizing patients into three groups based on their response patterns.
Research finds that following a low-calorie diet is associated with a heightened risk of depressive symptoms, especially in men who are overweight. The study analyzed data from over 28,500 adults and found that calorie-restrictive diets were linked to higher cognitive-affective symptom scores in men.
Professor Benedetti's research explores the intersection of genetics, environmental factors, and treatment response in mood disorders. His work has led to breakthroughs in chronotherapeutics and immuno-psychiatry, revealing crucial insights into immune-inflammatory mechanisms and gene variants influencing brain function.
A WVU microbiology student has discovered a new species of fungus, Periglandula clandestina, that produces effects similar to the semisynthetic drug LSD. The fungus is highly efficient at making ergot alkaloids, which can be used therapeutically to treat conditions like depression and addiction.
A new study has found that depression is linked to an increased risk of dementia in both midlife and late life. The research highlights the importance of recognizing and treating depression across the life course to protect brain health.
Adolescents in India whose mothers experience domestic violence are at a significantly increased risk of developing anxiety and depression. The study highlights the importance of addressing this issue, particularly in Indian communities where domestic violence is prevalent.
A new study from the University of Texas at El Paso finds that adolescent antidepressant use, particularly Prozac, may contribute to increased pain sensitivity in adulthood. The research suggests that early exposure to these medications can disrupt brain development and increase inflammatory markers, leading to heightened pain perception.
A study found that oral microbiota transmission between spouses partially mediates symptoms of depression and anxiety. Couples with one partner experiencing depression and anxiety showed significant changes in their oral microbiota, which correlated with alterations in salivary cortisol levels.
A novel lab method developed by McGill University researchers has identified nine molecules in the blood that were elevated in teens diagnosed with depression. These molecules also predicted how symptoms might progress over time, providing a potential tool for early detection and treatment.
A new study published in Science suggests that ketamine's antidepressant effects can be sustained for up to two months by enhancing ERK activity with the drug BCI. This breakthrough could improve treatment outcomes for millions of people affected by major depressive disorder.
A cohort study of over 11,000 children and adolescents found a significant association between increased social media use and greater depressive symptoms. Clinicians are advised to provide guidance on social media use for young adolescents and their parents.
Researchers have identified a mechanism involving potassium channels that could provide a new approach to treating depression. The study, led by Dr. James Murrough, found that ezogabine improved depression symptoms and anhedonia in patients, normalizing brain activity in key regions.
A new strategy for screening anxiety and depression in epilepsy patients has shown a significant increase in screening rates from 12.6% to 29.2% using an electronic health record-based approach. The study found that younger patients and white patients were more likely to complete the screeners.
A systematic review of studies found that policies improving paid parental leave, employment access, housing stability, and income support are associated with lower rates of depression. Conversely, cuts to social welfare and financial insecurity increase depression risk, particularly among single parents and low-income households.
A new study published in JAMA Network Open found that as preteens used more social media, their depressive symptoms increased by 35%. The research team tracked changes over time in each child to accurately assess the link between social media and depression. Experts suggest using digital habits tools to create healthier online behavior...
A new study found that people taking antidepressants for over two years are more likely to experience withdrawal symptoms, including anxiety and fatigue. Long-term users also tend to have worse withdrawal symptoms and are less able to stop taking the medication.
A new study from Kennedy Krieger Institute reveals nearly 40% of pediatric patients with long COVID report significant symptoms of anxiety or depression. The study highlights the importance of integrating mental health screening into care for children with long COVID to improve quality of life.
Research found that women whose sister experienced postpartum psychosis are over 10 times more likely to experience it themselves. The study highlights genetic and shared environmental influences and suggests early recognition and prevention are crucial.
A study by University College London researchers found that depressive symptoms worsen long before pain begins in middle-aged and older adults. Early mental health interventions may help prevent or reduce later aches and pains.
Depressive symptoms among older stroke survivors in China were found to be prevalent, with central symptoms including feeling blue, nervousness, and loneliness. These symptoms had a significant negative impact on quality of life.
A systematic review and meta-analysis found that calorie restrictive and low-fat diets may reduce depression symptoms in those with high cardiometabolic risk. However, the evidence is limited, and researchers recommend further exploration of dietary interventions alongside first-line treatment for depression and/or anxiety.
Researchers found that specific combinations of personality traits can predict bipolar disorder outcomes, with certain styles raising and others lowering the risk of depression. The study used data from over 2,500 people with bipolar disorder and suggests a personalized approach to treatment planning.
A new clinical trial found mindfulness-based cognitive therapy (MBCT) significantly improved depression symptoms compared to continued treatment as usual. MBCT was also shown to be cost-effective, saving the NHS money by changing service use.
GLP1-RA treatment is associated with improvements in quality of life, restrained eating, and emotional eating behavior. The treatment also provides reassurance regarding its psychiatric safety profile.
Long sleep duration is associated with poorer global cognition and specific cognitive abilities like memory, visuospatial skills and executive functions. This association is strongest in people with depressive symptoms, regardless of antidepressant usage.
A large-scale UK biobank study found that loneliness increases the risk of hearing loss, with a 24% higher risk for lonely individuals compared to non-lonely counterparts. The study also identified distinct pathways through which loneliness contributes to hearing loss, including inflammation and chronic diseases.
A study published in Behavior Therapy shows that a peer support program provides 'rapid relief of symptoms' and 'significant clinical improvement' to new moms struggling with postpartum depression. The program, Alma, pairs new and expectant moms with trained peers who have experienced similar mental health challenges.
Researchers identify enlarged salience network as first reliable biomarker for depression risk, predicting symptoms before they appear. The network's expansion could enable early identification and intervention, leading to improved quality of life and treatment outcomes.
A cohort study of US veterans found that depression is associated with a higher hazard of incident heart failure after controlling for demographic and cardiovascular risk factors. Depression remains consistent as a risk factor even in low-risk cohorts.
A new Vanderbilt University Medical Center-led study found US veterans with depression had a 14% higher risk of heart failure, even after adjusting for traditional risk factors. The study suggests that screening and treating depression may help prevent future heart failure in patients.
A study published in Alzheimer's & Dementia found that learning one's Alzheimer's risk can decrease negative emotions like depression and anxiety, but also leads to decreased motivation for maintaining healthy lifestyle changes. Researchers emphasize the importance of personalized disclosure processes to sustain healthy behaviors.
The Psychedelics journal has expanded its focus to include all psychoactive drugs, challenging traditional classifications and embracing a broader understanding of consciousness-altering substances. This move aims to reveal novel therapeutic applications and deepen human knowledge of the mind.
A new study by the University of Ottawa reveals a clear link between racism in schools and symptoms of depression among Black students. The research identifies how academic racism hinders Black youths and their social and economic contribution to Canadian society.
Researchers have discovered terahertz light waves can reduce hyperactivity in brain regions associated with depression, leading to rapid improvements in mood and thinking ability. The treatment works without introducing foreign substances into the brain and is safe for use at therapeutic intensities.
A study published in Journal of the American Academy of Child & Adolescent Psychiatry found that adolescents who are more physically active have a lower risk of developing depression symptoms. The research followed 873 participants from age 6 to 18 and found that physical activity protected against depression symptoms in adolescence.
The COVID-19 pandemic led to a substantial increase in depressive symptoms among US adults, with younger individuals being disproportionately affected. Worsening mental health trends were observed across the population.
Children from disadvantaged neighborhoods show blunted response to reward and loss, especially those with family history of depression. Growing up in chronically stressful environments may dampen reaction to good or bad events, increasing depression risk.
A new study finds that Medicaid unwinding disrupted kids' and young adults' access to chronic disease medication, particularly for those living in states with the largest drops in Medicaid enrollment. The disruptions led to increased use of private insurance or cash for prescriptions, exacerbating health issues.
Previous depression survivors exhibit reduced motivation for everyday tasks but become equally motivated with large and certain rewards. This research sheds light on subtle motivational deficits persisting in recovered depression, guiding targeted treatment for sustained recovery.
A new study reveals a concerning rise in type 2 diabetes among depression inpatients in Beijing from 2005 to 2018. Depression and type 2 diabetes co-occurrence is understudied, but the research found 9.13% of depression patients had T2DM, with significant age, sex, and socioeconomic factors linked to elevated risk.
Researchers analyzed medical claims data to identify increased risks of heart failure, atrial fibrillation, and fractures among breast cancer survivors. The study highlights the importance of preventive care for these individuals.